Language selection

Search

Details for: LOVENOX

Company: SANOFI-AVENTIS CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02012472LOVENOXENOXAPARIN SODIUM30 MG / 0.3 MLSOLUTIONSUBCUTANEOUS
02236883LOVENOXENOXAPARIN SODIUM40 MG / 0.4 MLSOLUTIONSUBCUTANEOUS
02378426LOVENOXENOXAPARIN SODIUM60 MG / 0.6 MLSOLUTIONSUBCUTANEOUS
02378434LOVENOXENOXAPARIN SODIUM80 MG / 0.8 MLSOLUTIONSUBCUTANEOUS
02236564LOVENOX WITH PRESERVATIVE 300MG/3MLENOXAPARIN SODIUM100 MG / MLSOLUTIONINTRAVENOUS
02378442LOVENOXENOXAPARIN SODIUM100 MG / MLSOLUTIONSUBCUTANEOUS
02236564LOVENOX WITH PRESERVATIVE 300MG/3MLENOXAPARIN SODIUM100 MG / MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Summary Safety Review - Low-Molecular-Weight Heparins - Assessing the potential risk of bleeding in or around the spinal cord (Spinal/Epidural Hematoma)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: